| Summary: | A new family of pyrazole-based compounds (<b>1</b>–<b>15</b>) was synthesized and characterized using different physicochemical analyses, such as FTIR, UV-Visible, <sup>1</sup>H, <sup>13</sup>C NMR, and ESI/LC-MS. The compounds were evaluated for their in vitro antifungal and antibacterial activities against several fungal and bacterial strains. The results indicate that some compounds showed excellent antibacterial activity against <i>E. coli</i>, <i>S. aureus</i>, <i>C. freundii</i>, and <i>L. monocytogenes</i> strains. In contrast, none of the compounds had antifungal activity. Molecular electrostatic potential (MEP) map analyses and inductive and mesomeric effect studies were performed to study the relationship between the chemical structure of our compounds and the biological activity. In addition, molecular docking and virtual screening studies were carried out to rationalize the antibacterial findings to characterize the modes of binding of the most active compounds to the active pockets of NDM1 proteins.
|
|---|